Prof. Mona O. Mohsen is an Associate Professor at the University of Bern, Switzerland, and Chief Executive Officer of DeepVax and DeepVax Longevity GmbH. She earned her D.Phil. in Clinical Medicine from the University of Oxford and completed advanced research training at Harvard Medical School and The University of Texas MD Anderson Cancer Center. Her research focuses on translational medicine, cancer immunotherapy, vaccine development, and nanobiotechnology, with an emphasis on translating innovative immunotherapies into clinical applications. With an h-index of 33, she is ranked among the leading researchers at the University of Bern and in Switzerland. Dr. Mohsen has published extensively in high-impact journals and is committed to advancing biomedical innovation through research, entrepreneurship, and international collaboration.